KANSAS CITY, Kan., Dec. 28, 2017 /PRNewswire/ — Cingulate Therapeutics, LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its precision timed release drug delivery platform technology, today announced that Cingulate’s…